IDEAL: IDENTIFICATION AND CHARACTERISATION OF NEW THERAPEUTIC APPROACHES AGAINST CANCER (Q2023975)

From EU Knowledge Graph
Revision as of 04:05, 20 March 2020 by DG Regio (talk | contribs) (‎Changed an Item)
Jump to navigation Jump to search
Project in Italy financed by DG Regio
Language Label Description Also known as
English
IDEAL: IDENTIFICATION AND CHARACTERISATION OF NEW THERAPEUTIC APPROACHES AGAINST CANCER
Project in Italy financed by DG Regio

    Statements

    country
    Italy
    0 references
    EU contribution
    781,317.04 Euro
    0 references
    budget
    1,041,756.09 Euro
    0 references
    co-financing rate
    75.0 percent
    0 references
    start time
    31 October 2018
    0 references
    expected end time
    30 April 2020
    0 references
    beneficiary name (string)
    UNIVERSITA' DEGLI STUDI DELLA CAMPANIA LUIGI VANVITELLI
    0 references
    BIOGEM IRGS ISTITUTO DI RICERCHE GENETICHE
    0 references
    BIOPULSE S.R.L.
    0 references
    EPI-C S.R.L.
    0 references
    PENTA TECHNOLOGY S.R.L.
    0 references
    beneficiary
    Q267495
    0 references
    Q278442
    0 references
    Q278622
    0 references
    Q278623
    0 references
    Q278560
    0 references
    coordinate location

    40°50'9.35"N, 14°14'55.61"E
    0 references
    summary
    IDEAL INTENDE REALIZZARE UNA NUOVA SOLUZIONE TECNOLOGICA: UN NUOVO PRODOTTO (MOLECOLA ANTICANCRO SU BASE EPIGENETICA), UN NUOVO METODO DI DELIVERY (BASATO SULLA ELETTROPORAZIONE IN VIVO), UN SISTEMA DI INTEGRAZIONE DI DATI MOLECOLARI DI IMAGING UTILE PER LA PREVISIONE DELLA RISPOSTA A TRATTAMENTO E DUNQUE STRATIFICAZIONE PAZIENTI FINO ALL'AVANZATA FASE PRECLINICA. (Italian)
    0 references

    Identifiers

    Italian Unique Project Code
    B63D18000560007
    0 references
     
    Retrieved from "https://linkedopendata.eu/w/index.php?title=Item:Q2023975&oldid=2480394"